PRESS RELEASE published on 11/14/2025 at 16:05, 3 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. files Form 8.3 disclosing a 4.89% stake in NCC Group plc as of 13 November 2025 Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure NCC Group Plc
PRESS RELEASE published on 11/14/2025 at 16:04, 3 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses a 4.96% interest in Unite Group plc. Dealings include the sale of 25p ordinary securities at 5.60 GBP per unit Vanguard Group Financial Disclosure Securities Trading Stock Market Unite Group Plc
PRESS RELEASE published on 11/14/2025 at 16:02, 3 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Spectris plc The Vanguard Group, Inc. discloses 5.57% interest in Spectris plc. Form 8.3 filing under Takeover Code on 14-Nov-2025 Form 8.3 The Vanguard Group Takeover Code Spectris Plc 14-Nov-2025
PRESS RELEASE published on 11/14/2025 at 16:01, 3 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Big Yellow Group plc The Vanguard Group, Inc. discloses 5.54% interest in Big Yellow Group plc as of 13 Nov 2025 in accordance with Rule 8.3 of the Takeover Code Disclosure Rule 8.3 Takeover Code Vanguard Group Big Yellow Group Plc
BRIEF published on 11/13/2025 at 16:14, 3 months 28 days ago The Vanguard Group Discloses Position in Qualcomm Takeover Code Stock Trading Securities Disclosure Vanguard Group Qualcomm
BRIEF published on 11/13/2025 at 16:13, 3 months 28 days ago The Vanguard Group Discloses Position in American Axle & Manufacturing Securities Form 8.3 Takeover Code Vanguard Group American Axle
BRIEF published on 11/13/2025 at 16:12, 3 months 28 days ago The Vanguard Group's Disclosure on JTC plc Stake The Vanguard Group Takeover Code Stake Disclosure Share Transactions JTC Plc
BRIEF published on 11/13/2025 at 16:10, 3 months 28 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Disclosure Irish Takeover Panel Vanguard Group Avadel Pharmaceuticals
PRESS RELEASE published on 11/13/2025 at 16:09, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.64% interest in Qualcomm Incorporated. Deals involving USD 0.0001 common stock include purchases and sales The Vanguard Group Financial Disclosure Interest Disclosure Stock Dealings Qualcomm Incorporated
BRIEF published on 11/13/2025 at 16:09, 3 months 28 days ago The Vanguard Group Files Disclosure on Mural Oncology plc Ordinary Shares Irish Takeover Panel Securities Disclosure Vanguard Mural Oncology
Published on 03/12/2026 at 15:00, 20 minutes ago PPX Advances Permitting Process for Electrical Transmission Line to the Igor Processing Plant
Published on 03/12/2026 at 13:16, 2 hours 4 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 03/12/2026 at 13:00, 2 hours 20 minutes ago Justera Announces Director and Interim CEO Appointments
Published on 03/12/2026 at 12:30, 2 hours 50 minutes ago Nextech3D.ai Signs Three-Year Enterprise 3D Modeling and Augmented Reality E-Commerce Contract Valued at Approximately $175,000
Published on 03/12/2026 at 14:40, 39 minutes ago J.S. Held Launches AI Disputes Monitor to Track Rapidly Growing AI Litigation Landscape
Published on 03/12/2026 at 14:28, 51 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/12/2026 at 15:06, 13 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 10:55, 4 hours 24 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 7 hours 50 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/11/2026 at 18:30, 20 hours 49 minutes ago Filing of the 2025 TF1 Universal Registration Document
